Jul 31, 09:07
AnnouncementsGranules India: Outcome of board meeting
73% of moneycontrol users recommend buying Granules India.
What's your call on Granules India today?
Read 99 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||2807.40||-0.53||2939.80||2140.35||47,819.86|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|No Mutual Funds Holding the share|
Jindal PolyFilms Recommended on May 27th 2014
Recommended price 177.00 | Peak from reco 278.40 57.29%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Granules India is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 1,288.64 crore.The company has reported a consolidated sales of Rs 311.02 crore and a Net Profit of Rs 22.87 crore for the quarter ended Jun 2014.
The company management includes C Nageswara Rao - Chairman, C Krishna Prasad - Managing Director, L S Sarma - Independent Director, A P Kurian - Independent Director, C Parthasarathy - Independent Director, Krishna Murthy Ella - Independent Director, Arun Rao Akinepally - Independent Director, Harsha Chigurupati - Executive Director, Uma Chigurupati - Executive Director, K B Sankara Rao - Additional Director.
It is listed on the BSE with a BSE Code of 532482 and the NSE with an NSE Code of GRANULES.
Its Registered office is at 2nd Floor, 3rd Block,,My Home Hub, Hyderabad,Andhra Pradesh - 500081.
Their Registrars are Cil Securities Ltd.